AIDS research and therapy · 2026
Beyond HIV: investigating key drivers of metabolic syndrome in midlife women with HIV in the INSTI era.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Poliseno M, Brindicci G, Capruzzi D, Cianciaruso A, Colavito N, Giliberti V, Lobalsamo V, Metrangolo G, Milano E, Perrucci L, Santoro C R, Vigna A, Di Gennaro F, Saracino A
Аннотация
BACKGROUND: The contribution of lifestyle factors compared with HIV infection and antiretroviral therapy (ART)-related determinants to Metabolic Syndrome (MetS) in Women with HIV (WWH) remains uncertain.
OBJECTIVES: To evaluate the prevalence and determinants of MetS in the era of Integrase Strand Transfer Inhibitors (INSTI).
DESIGN: Monocentric retrospective cohort study.
METHODS: We analyzed 297 WWH to assess the prevalence of MetS and its association with HIV-related and lifestyle factors.
RESULTS: MetS was diagnosed in 80 women (26%). Those with MetS showed lower CD4 nadir, longer HIV and ART duration, and greater exposure to protease inhibitors and INSTI, but none were independently associated with MetS or its components. Notably, lifestyle-related factors showed relatively strong associations with the study outcomes: physical activity was protective (OR 0.10, 95% CI 0.02-0.44), whereas physically demanding work increased risk (OR 6.58, 95% CI 2.03-26.26).
CONCLUSIONS: Lifestyle-related factors appeared to show stronger associations with MetS risk compared to HIV-related variables, underscoring the importance of systematic lifestyle assessment and targeted interventions in women with HIV.
OBJECTIVES: To evaluate the prevalence and determinants of MetS in the era of Integrase Strand Transfer Inhibitors (INSTI).
DESIGN: Monocentric retrospective cohort study.
METHODS: We analyzed 297 WWH to assess the prevalence of MetS and its association with HIV-related and lifestyle factors.
RESULTS: MetS was diagnosed in 80 women (26%). Those with MetS showed lower CD4 nadir, longer HIV and ART duration, and greater exposure to protease inhibitors and INSTI, but none were independently associated with MetS or its components. Notably, lifestyle-related factors showed relatively strong associations with the study outcomes: physical activity was protective (OR 0.10, 95% CI 0.02-0.44), whereas physically demanding work increased risk (OR 6.58, 95% CI 2.03-26.26).
CONCLUSIONS: Lifestyle-related factors appeared to show stronger associations with MetS risk compared to HIV-related variables, underscoring the importance of systematic lifestyle assessment and targeted interventions in women with HIV.